Navigation Links
ARIUS announces first quarter fiscal 2008 financial results
Date:4/11/2008

rent liabilities:

Accounts payable and accrued liabilities 1,796,442 2,034,972

Accrued loss on embedded foreign exchange

derivative 317,176 296,064

Current portion of leasehold inducements 41,484 41,484

Current portion of capital lease obligation 21,674 25,710

Current portion of deferred revenue 1,726,694 1,991,413

-----------------------------------------------------------------------

3,903,470 4,389,643

Leasehold inducements 224,920 235,291

Capital lease obligation - 2,224

Deferred revenue 1,527,304 1,758,898

Shareholders' equity:

Share capital:

Common shares 30,484,195 28,644,454

Warrants 10,432,417 9,603,644

Compensation warrants - 912,377

Contributed surplus 2,501,856 2,355,378

Deficit (35,117,714) (32,533,633)

-----------------------------------------------------------------------

8,300,754 8,982,220

-------------------------------------------------------------------------

13,956,448 15,368,276

-------------------------------------------------------------------------

-------------------------------------------------------------------------

ARIUS RESEARCH INC.

(A DEVELOPMENT STAGE COMPANY)

INTERIM STATEMENTS OF OPERATIONS, COMPREHENSIVE LOSS AND DEFICIT

(Unaudited)

--------------------------------------------------
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
2. ARIUS Announces Third Quarter Fiscal 2007 Financial Results
3. Arius highlighted at AACR-NCI-EORTC 2007 International Cancer Conference
4. ARIUS to present at Chinese Global Financial Forum
5. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
6. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
7. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
8. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
9. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
10. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
11. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... On behalf of biotech client GenScript ... Goldman & Spitzer, P.A. (Wilentz) secured a significant jury ... in excess of $10 million. The jury determined that ... that it improperly hired one or more of GenScript,s ... judgment notwithstanding the verdict, a new trial, and remittitur. ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015   Regulus ... biopharmaceutical company leading the discovery and development of innovative ... Xanthopoulos , Ph.D., President and Chief Executive Officer of ... and Company 35 th Annual Healthcare Conference on ... conference is being held at the Boston Marriott Copley ...
(Date:2/26/2015)... Woodbridge, NJ (PRWEB) February 26, 2015 ... and its affiliated companies, Wilentz, Goldman & ... in a trade secrets lawsuit against Genewiz Inc. in ... illegally obtained and utilized GenScript’s trade secrets, and that ... The court entered an order denying motions for ...
(Date:2/26/2015)... PA (PRWEB) February 26, 2015 ... 9 -12, at the Ernest N. Morial Convention ... exhibitors (count as of February 19, 2015) displaying ... in industrial, academic, and government labs. The Exposition ... as, but not limited to, analytical chemistry; drug ...
Breaking Biology Technology:Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Pittcon 2015 Announces Exposition Highlights 2
... March 3-9, SAN CARLOS, Calif., March 4 ... According to the National Sleep,Foundation,s Sleep in America poll, ... interest in sex because of sleepiness due to working,an ... per week at home. Many,may also suffer from Obstructive ...
... quality, on-demand content for medical ... ... Healthcare professionals who use,Advanstar,s ModernMedicine.com will experience enhanced Web search ... the medical professional,s search engine.,ModernMedicine.com is an innovative, online clinical ...
... FRANCISCO, Calif., March 4 Sunesis,Pharmaceuticals, Inc. (Nasdaq: ... anticancer therapeutics, will present data at the,upcoming 39th ... Society of,Gynecologic Oncologists (SGO). This year,s conference will ... Center in Tampa, Fla., Interim data from ...
Cached Biology Technology:SleepQuest Raises Awareness of Sleep Disorders 2Partnership With SearchMedica.com to Enhance Web Searches on ModernMedicine.com 2Partnership With SearchMedica.com to Enhance Web Searches on ModernMedicine.com 3Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Women's Cancer 2
(Date:2/5/2015)... TRIANGLE PARK, North Carolina , 5. ... sein 35. Jahr als spezialisiertes Logistikunternehmen und ... Position als einzige klinische Logistikfirma (Clinical Logistics ... Die Kernbotschaft der neuen Kampagne lautet ... und Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... 26, 2015   Epic Sciences , a precision diagnostics ... that Murali Prahalad , Ph.D., president and CEO, is ... (PMWC) 2015: Silicon Valley, which is taking place at ... on January 26-28, 2015. Dr. ... as Biomarkers." Last year, Epic Sciences was a finalist in ...
(Date:2/5/2015)... IRVINE, Calif. , Jan. 27, 2015 ... trusted provider of globally deployed, innovative test ... today announced the delivery of its ... Martin Space Systems Company (LMSSC). GENASYS is ... the demands of mission-critical applications that require ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... University of Colorado at Boulder indicates biologists trying to ... the past several decades through hatchery propagation and restocking ... fish. According to a sophisticated DNA analysis, five ... be greenback cutthroat trout living in isolated pockets of ...
... Neurons, or nerve cells, communicate with each other ... damaged, communication breaks down, causing the messages that would ... our mind locate our car keys to fall short. ... at Chapel Hill School of Medicine have shown that ...
... Initiative, has signed a $7.8 million, two-year contract with ... establish a collection of DNA samples for autism studies. ... have a single autistic child. The Simons Simplex ... core resource for a new and different line of ...
Cached Biology News:New study shows greenback cutthroat trout involved in recovery effort misidentified 2New study shows greenback cutthroat trout involved in recovery effort misidentified 3Specific brain protein required for nerve cell connections to form and function 2Rutgers Genetics receives $7.8 million for autism research 2Rutgers Genetics receives $7.8 million for autism research 3
Antibody specific for trimethyl-Lys27 of histone H3. Mouse monoclonal. Antigen: Synthetic peptide derived from histone H3, trimethylated at lysine 27...
DTT 50 l...
Rabbit polyclonal to Staphylococcus Enterotoxin E (Biotin) ( Abpromise for all tested applications)....
...
Biology Products: